JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Lipid infusion and high fat feeding are established causes of systemic and adipose tissue insulin resistance. In this study, we treated 3T3-L1 adipocytes with a mixture of free fatty acids (FFAs) to investigate the molecular mechanisms underlying fat-induced insulin resistance. FFA treatment impaired insulin receptor-mediated signal transduction and decreased insulin-stimulated GLUT4 translocation and glucose transport. FFAs activated the stress/inflammatory kinases c-Jun N-terminal kinase (JNK) and IKKbeta, and the suppressor of cytokine signaling protein 3, increased secretion of the inflammatory cytokine tumor necrosis factor (TNF)-alpha, and decreased secretion of adiponectin into the medium. RNA interference-mediated down-regulation of JNK blocked JNK activation and prevented most of the FFA-induced defects in insulin action. Blockade of TNF-alpha signaling with neutralizing antibodies to TNF-alpha or its receptors or with a dominant negative TNF-alpha peptide had a partial effect to inhibit FFA-induced cellular insulin resistance. We found that JNK activation by FFAs was not inhibited by blocking TNF-alpha signaling, whereas the FFA-induced increase in TNF-alpha secretion was inhibited by RNA interference-mediated JNK knockdown. Together, these results indicate that 1) JNK can be activated by FFAs through TNF-alpha-independent mechanisms, 2) activated JNK is a major contributor to FFA-induced cellular insulin resistance, and 3) TNF-alpha is an autocrine/paracrine downstream effector of activated JNK that can also mediate insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [26]
In the citing paper
“However, FFAs can also serve as ligands for the TLR4 complex (33), thereby activating the classical inflammatory response in the context of increased local extracellular lipid concentrations, which ultimately drives ATMΦ accumulation (34,35).”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Research works printed but not linked: 1
- Worrall, D. S., and Olefsky, J. M. (2002) Mol. Endocrinol. 16, 378 -389 · doi:10.1210/mend.16.2.0776 · Paper page
Cited by
Items 201–300 of 418
Animal Models in Diabetic Research—History, Presence, and Future Perspectives
Pandey, S., Chmelir, T., & Dvorakova, M. C. (2023) · Biomedicines · doi:10.3390/biomedicines11102852 · Cited by 38
“It has been observed that FFA treatment can impair insulin receptor-mediated signal transduction, which may alter GLUT4 translocation and can diminish glucose transport and finally induce cellular insulin resistance via the activated JNK pathway or via TNF-alpha-independent mechanisms [157].”
BackgroundLi, X., Jiang, L., Yang, M., Wu, Y., Sun, J., & Sun, S. (2014) · Endokrynologia Polska · doi:10.5603/ep.2014.0034 · Cited by 42
Miao, X., Wang, Y., Wang, W., Lv, X., Wang, M., & Yin, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.017 · Cited by 39
“Contents lists available at ScienceDirect Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/ locate /mce led to increased expression of several proinflammatory cytokines including TNF-α, interleukin-1β (IL-1β), IL6 and MCP-1 (Boden et al., 2005).”
BackgroundInfluentialPalmitic acid causes insulin resistance in granulosa cells via activation of JNK
Xu, L., Wang, W., Zhang, X., Ke, H., Qin, Y., Li, Y., Li, W., Lü, G., Chan, W., Leung, P. C. K., et al. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0214 · Cited by 37
Soliman, S., Aronson, W. J., & Barnard, R. J. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep031 · Cited by 36
“[18, 19] reported that fatty acids increase inflammatory cytokine production in both monocytes and adipocytes by activating toll-like receptors 2 and 4.”
BackgroundPlaisance, E. P., Grandjean, P. W., Judd, R. L., Jones, K. W., & Taylor, K. J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.038 · Cited by 40
Park, S. Y., Lee, J. H., Kim, K. Y., Kim, E. K., Yun, S. J., Kim, C. D., Lee, W. S., & Hong, K. W. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.006 · Cited by 35
Spigoni, V., Fantuzzi, F., Fontana, A., Cito, M., Derlindati, E., Zavaroni, I., Cnop, M., Bonadonna, R. C., & Dei, A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.004 · Cited by 35
Dopaminergic Pathways in Obesity-Associated Inflammation
Leite, F., & Ribeiro, L. V. P. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09863-0 · Cited by 35
“…TLR4 and c-jun N-terminal kinase (JNK)dependent pathways, promotes ATM M1 polarization expressing cytokines like TNF-α, IL-6, and IL-1β in response to LPS and interferon δ (IFN-δ), with the capacity of blocking insulin action (Lumeng et al. 2007a, b; Nguyen et al. 2005, 2007; Hevener et al. 2007).”
BackgroundEndogenous CSE/H2S system mediates TNF‐α‐induced insulin resistance in 3T3‐L1 adipocytes
Huang, C., Yao, W., Wu, W., Lu, Y., Wan, H., & Wang, W. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2920 · Cited by 34
Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice
Yu, X. X., Murray, S. F., Watts, L. M., Booten, S. L., Tokorcheck, J., Monia, B. P., & Bhanot, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00629.2007 · Cited by 37
“Activation of JNK in vitro increased serine phosphorylation of IRS-1 and decreased its tyrosine phosphorylation, thereby causing inhibition of cellular insulin signaling (1, 21).”
BackgroundHelsley, R. N., Sui, Y., Park, S., Liu, Z., Lee, R. G., Zhu, B., Kern, P. A., & Zhou, C. (2016) · Stem Cells · doi:10.1002/stem.2358 · Cited by 38
Li, Z., Xu, K., Guo, Y., Ping, L., Gao, Y., Qiu, Y., Ni, J., Liu, Q., & Wang, Z. (2020) · Aging Cell · doi:10.1111/acel.13104 · Cited by 35
“It has been demonstrated that a high-fat diet can decrease p-IR levels and inhibit the activation of AKT, and also decrease glucose uptake and promote insulin resistance (Nguyen et al., 2005; Ramalho et al., 2017; Singh et al., 2016; Sodhi et al., 2012).”
BackgroundToll-Like Receptors, Their Ligands, and Atherosclerosis
Hodgkinson, C. P., & Ye, S. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.36 · Cited by 35
“Free fatty acids, the levels of which increase in obesity, are believed to cause insulin resistance in vivo by activating proinflammatory signaling pathways in adipocytes[114,115,116,117].”
BackgroundCurcumin inhibits adipogenesis induced by benzyl butyl phthalate in 3T3-L1 cells
Sakuma, S., Sumida, M., Endoh, Y., Kurita, A., Yamaguchi, A., Watanabe, T., Kohda, T., Tsukiyama, Y., & Fujimoto, Y. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.036 · Cited by 34
Dordevic, A. L., Konstantopoulos, N., & Cameron‐Smith, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099382 · Cited by 34
“Previous studies have explored the effect of mixed FA in adipocytes and have demonstrated increased JNK and IkB kinase (IKK) phosphorylation (the latter responsible for NF-kB activation) and reduced glucose uptake after 1 h [53] as well as increased gene expression levels of TLR2 gene after 8 hours [54], and TLR4 afte…”
BackgroundNitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes
野崎, 真., Fukuhara, A., Segawa, K., Okuno, Y., Abe, M., Hosogai, N., Matsuda, M., Komuro, R., & Shimomura, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.084 · Cited by 34
Kain, V., Kapadia, B. B., Viswakarma, N., Seshadri, S., Prajapati, B., Jena, P. K., Meda, C. L. T., Subramanian, M., Suraj, S. K., Kumar, S. T., et al. (2015) · Scientific Reports · doi:10.1038/srep15197 · Cited by 35
Hivert, M., SULLIVAN, L. M., Shrader, P., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Wilson, P. W. F., Benjamin, E. J., & Meigs, J. B. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.017 · Cited by 35
“In vitro, NEFA have been shown to decrease adiponectin secretion and to increase TNFα secretion in adipocytes [33].”
BackgroundChapter 5 CXCL14 and Insulin Action
Hara, T., & Nakayama, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00605-5 · Cited by 32
“In obese individuals, white adipose tissue (WAT) secretes increased amounts of free fatty acids and inflammatory cytokines, including tumor necrosis factor-a (Nguyen et al., 2005; Uysal et al., 1997) and interleukin (IL)-6 (Cai et al., 2005).”
BackgroundBenzler, J., Ganjam, G. K., Legler, K., Stöhr, S., Krüger, M., Steger, J., & Tups, A. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12018 · Cited by 35
Russart, K. L. G., Chbeir, S., Nelson, R. J., & Magalang, U. J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116574 · Cited by 32
“Stress and inflammatory response pathways, which can be activated by free fatty acids, are key signaling mechanisms through which IRS1 can be phosphorylated at Ser307 [55,56].”
BackgroundSaben, J. L., Thakali, K. M., Lindsey, F., Zhong, Y., Badger, T. M., Andres, A., & Shankar, K. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214539225 · Cited by 34
Zyromski, N. J., Mathur, A., Gowda, G. A. N., Murphy, C. J., Swartz‐Basile, D. A., Wade, T. E., Pitt, H. A., & Raftery, D. (2009) · Pancreatology · doi:10.1159/000199436 · Cited by 37
Zan, P., Than, A., Leow, M. K., Cai, H. X., Wen, H., Zhang, Z., & Chen, P. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149395 · Cited by 33
Human Protein Kinases and Obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_5 · Cited by 34
Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes
Chen, S., Sbuh, N., & Veedu, R. N. (2021) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0891 · Cited by 30
Wen, Y., Wang, H., MacLaren, R., Wu, J., Lü, H., & Cianflone, K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21631 · Cited by 30
“3T3-L1 preadipocyte/ adipocyte cell models have commonly been used to examine insulin resistance, usually using insulin stimulation of glucose transport as a marker of insulin response [Van Epps-Fung et al., 1997; Gao et al., 2004; Nguyen et al., 2005].”
BackgroundMethodResultInfluentialRole of Adipose Tissue in Metabolic System Disorders
Rezaee, F. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s13-008 · Cited by 37
Du, X., Liu, M., Tai, W., Yu, H., Hao, X., Loor, J. J., Jiang, Q., Fang, Z., Gao, X., Fan, M., et al. (2022) · Journal of Dairy Science · doi:10.3168/jds.2022-22009 · Cited by 30
Permana, P. A., Zhang, W., Wabitsch, M., Fischer‐Posovszky, P., Duckworth, W. C., & Reaven, P. D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91013.2008 · Cited by 31
“The adipokines and FFAs produced by adipocytes activated with M -factors can, in turn, exert proinflammatory effects on adipocytes (38) and monocytes/macrophages (51, 52, 62), creating a self-propagating cycle of inflammation in adipose tissue.”
BackgroundXie, Y.-L., Pan, Y.-E., Chang, C., Tang, P., Huang, Y., Walzem, R. L., & Chen, S. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2012.07.004 · Cited by 29
Morelli, S., Piscioneri, A., Guarnieri, G., Morelli, A., Drioli, E., & Bartolo, L. D. (2020) · BioFactors · doi:10.1002/biof.1701 · Cited by 29
“Several molecular studies provided evidences that inflammatory responses are mediated by JNK activation.(39) Recently, Tse et al.”
BackgroundCho, Y. M., Kim, D. H., Lee, K. H., Jeong, S., & Kwon, O. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0131-0 · Cited by 29
Jakovljevic, N. K., Pavlović, K., Zujovic, T., Kravic‐Stevovic, T., Jotić, A., Marković, I., & Lalic, N. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.10.001 · Cited by 29
Protein Kinases in Obesity, and the Kinase-Targeted Therapy
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_7 · Cited by 29
Green, C., Bunprajun, T., Pedersen, B. K., & Schéele, C. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.251421 · Cited by 29
“and fatty acids and promotes serine phosphorylation of IRS proteins (Nguyen et al. 2005).”
BackgroundFernández‐Galilea, M., Félix‐Soriano, E., Colón-Mesa, I., Escoté, X., & Moreno-Aliaga, M. J. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00720-5 · Cited by 30
“SFAs activate several inflammatory signaling responses, including a broad pattern of cytokine release, in several cell types such as macrophages, adipocytes, myocytes, and hepatocytes [37, 72, 73, 124].”
BackgroundVijay‐Kumar, M., Aitken, J. D., Carvalho, F. A., Ziegler, T. R., Gewirtz, A. T., & Ganji, V. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-2 · Cited by 29
Hu, W., Kang, Q., Zhang, C., Ma, H., Xu, C., Wan, Y., & Hu, J. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114474 · Cited by 28
Fukuoka, H., Iida, K., Nishizawa, H., Imanaka, M., Takeno, R., Iguchi, G., Takahashi, M., Okimura, Y., Kaji, H., Chihara, K., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.02.001 · Cited by 26
Rozo, A. V., Vijayvargia, R., Weiss, H. R., & Ruan, H. (2008) · Diabetologia · doi:10.1007/s00125-008-1036-6 · Cited by 28
“The c-Jun N-terminal kinases (JNKs), key regulators of both cell proliferation and growth, and apoptosis and metabolism [13–17], are activated by NEFA [ 18 , 19] and pro-inflammatory cytokines [15].”
BackgroundPioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes
Kudoh, A., Satoh, H., Hirai, H., & Watanabe, T. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.04.001 · Cited by 25
“Glucose uptake was initiated as described previously (Nguyen et al., 2005), with some modifications.”
BackgroundMethodInfluentialSelf-citationYang, M., Dai, J., Jia, Y., Suo, L., Li, S., Guo, Y., Liu, H., Li, L., & Yang, G. (2014) · FEBS Journal · doi:10.1111/febs.12853 · Cited by 25
Frangioudakis, G., & Cooney, G. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0623 · Cited by 31
“The impact of IKK/NF-kB signalling on insulin action may also be tissue specific, since hepatic (Boden et al. 2005, Cai et al. 2005) and adipocyte (Nguyen et al. 2005) activation of this stress signalling pathway has recently been detected in insulin-resistant conditions.”
BackgroundJNK1 deficiency does not enhance muscle glucose metabolism in lean mice
Witczak, C. A., Hirshman, M. F., Jessen, N., FUJII, N. L., Seifert, M. M., Brandauer, J., Hotamışlıgil, G. S., & Goodyear, L. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.158 · Cited by 29
“Primary antibodies were obtained from commercial sources as follows: glycogen synthase (GS), glucose transporter 1 (GLUT1) and glucose transporter 4 (GLUT4) from Chemicon International, Inc., Temecula, CA; acetyl‐CoA‐carboxylase (ACC; streptavidin‐HRP antibody) from Pierce Biotechnology, Inc., Rockford, IL; JNK1/2 San…”
BackgroundInfluentialObesity; epiphenomenon or cause of metabolic syndrome?
Lois, K. B., Young, J., & Kumar, S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01773.x · Cited by 33
The importance of treating cardiometabolic risk factors in patients with type 2 diabetes
Barnett, A. H. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.002 · Cited by 30
“Increased plasma levels of FFAs have also recently been shown to induce insulin resistance through activation of the c-Jun N-terminal kinase (JNK) and through increased secretion of TNF-α in vitro and decreased expression of adiponectin.(30)”
BackgroundOng, M.-H.-L., Wong, H.-K., Muhammad, T. S. T., Choo, Q.-C., & Chew, C.-H. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04661-6 · Cited by 23
Therapeutic potential of antisense oligonucleotides for the management of dyslipidemia
Carpentier, A. C., Labbé, S. M., Grenier–Larouche, T., & Noll, C. (2011) · Clinical Lipidology · doi:10.2217/clp.11.60 · Cited by 26
Regulation of Insulin Clearance by Non-Esterified Fatty Acids
Najjar, S. M., Abdolahipour, R., Ghadieh, H. E., Jahromi, M. S., Najjar, J. A., Abuamreh, B. A. M., Zaidi, S., Kumarasamy, S., & Muturi, H. T. (2022) · Biomedicines · doi:10.3390/biomedicines10081899 · Cited by 22
“JNK activation produces TNFα that could, in turn, blunt insulin signaling by causing serine phosphorylation of IRS-1 [76].”
BackgroundKawamura, T., Murakami, K., Bujo, H., Unoki‐Kubota, H., Jiang, M., Nakayama, T., & Saitō, Y. (2008) · Experimental Biology and Medicine · doi:10.3181/0801-rm-20 · Cited by 23
“The treatment of 3T3L1 cells with FFAs was performed essentially according to the method previously described (15).”
InfluentialAdvances in the regulatory mechanisms of mTOR in necroptosis
Xie, Y., Zhao, G., Lei, X., Cui, N., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1297408 · Cited by 21
Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation
Gallo, K. A., Ellsworth, E. L., Stoub, H., & Conrad, S. E. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107457 · Cited by 22
Free Fatty Acids Impair FGF21 Action in HepG2 Cells
Asrih, M., Montessuit, C., Philippé, J., & Jornayvaz, F. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438540 · Cited by 21
Adochio, R., Leitner, J. W., Hedlund, R., & Draznin, B. (2008) · Endocrinology · doi:10.1210/en.2008-0437 · Cited by 22
Lavoie, F., Frisch, F., Brassard, P., Normand-Lauzière, F., Cyr, D., Gagnon, R., Drouin, R., Baillargeon, J., & Carpentier, A. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1021 · Cited by 23
Peterson, L. R., Jiang, X., Chen, L., Goldberg, A. C., Farmer, M. S., Ory, D. S., & Schaffer, J. E. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000669 · Cited by 20
Lordan, R., Τσούπρας, Α., & Zabetakis, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813792-5.00002-1 · Cited by 20
Measurement of the Unfolded Protein Response to Investigate Its Role in Adipogenesis and Obesity
Han, J., & Kaufman, R. J. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-800280-3.00008-6 · Cited by 21
“…free fatty acids (FFAs) induce expression of CHOP and BiP protein, increase Xbp1 mRNA splicing, and activate JNK in 3T3-L1 and rat primary adipocytes (Guo, Wong, Xie, Lei, & Luo, 2007; Nguyen et al., 2005), suggesting FFAs might exert adverse effects on adipose tissues through ER stress.”
BackgroundHarte, A. L., Tripathi, G., Piya, M. K., Barber, T. M., Clapham, J. C., Al‐Daghri, N. M., Aldisi, D. A., Kumsaiyai, W., Saravanan, P., Fowler, A. E., et al. (2013) · Obesity · doi:10.1002/oby.20336 · Cited by 27
Arumugam, M. K., Chava, S. P., Rasineni, K., Paal, M. C., Donohue, T. M., Osna, N. A., & Kharbanda, K. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-94180-x · Cited by 19
Neacsu, O., Cleveland, K., Xu, H., Tchkonia, T., Kirkland, J. L., & Boney, C. M. (2013) · Obesity · doi:10.1002/oby.20329 · Cited by 19
Odontella aurita-enriched diet prevents high fat diet-induced liver insulin resistance
Amine, H., Benomar, Y., Haimeur, A., Messaouri, H., Meskini, N., & Taouis, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0316 · Cited by 23
“…studies suggested that long chain saturated fatty acids promote insulin resistance through c-Jun N-terminal kinase (JNK) activation leading to the phosphorylation of insulin receptor substrate (IRS)1/2 on serine residues, then impairing insulin signaling (Nguyen et al. 2005, Solinas et al. 2006).”
BackgroundTous les acides gras saturés ont-ils le même effet métabolique ?
Walrand, S., Fisch, F., & Bourre, J. M. (2010) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2010.02.003 · Cited by 29
Liu, L., Lv, G., Ning, C., Yang, Y., & Zhu, J. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3242 · Cited by 18
“For example, TNF‑ α is a key downstream effectors of JNK‑mediated IR in 3T3‑L1 adipocytes (33).”
Obstructive sleep apnea and endothelial progenitor cells
Feng, J., Qing, W. A. N. G., Wu, Q., & Xin, S. U. N. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s51562 · Cited by 18
“In addition, increased sympathetic activity can cause an increase in inflammatory cytokines by increasing free fatty acid levels in the absence of ROS.”
Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?
Salazar, J. J., Chávez-Castillo, M., Rojas, J., Ortega, Á., Nava, M., Pérez, J. L., Rojas, M., Díaz, C. I. E., Chacín, M., Herazo, Y., et al. (2019) · Current Diabetes Reviews · doi:10.2174/1573399816666191230111838 · Cited by 18
Ho, J. H., Lee, O. K., Fu, Y.-J., Shih, H.-T., Tseng, C.-Y., Chung, C., Han, C., & Chen, Y. (2013) · Journal of Proteome Research · doi:10.1021/pr300662j · Cited by 17
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 19
Kim, T., Leitner, J. W., Adochio, R., & Draznin, B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.121 · Cited by 23
Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women
Gao, H. Y., Meng, J., Xing, H., Nie, S., Xu, M., Zhang, S., Jin, Y., Sun, T., Huang, H., Zhang, H., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu029 · Cited by 16
“Importantly, OS impairs glucose uptake in tissues, and results in IR and impaired insulin secretion, both in vitro (Nguyen et al., 2005; Gao et al., 2010) and in vivo (Furukawa et al.”
MORIYA, C. T., & Satoh, H. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3201534 · Cited by 16
“Mouse 3T3-L1 cells were cultured and differentiated as described previously [19, 20].”
BackgroundSelf-citationKim, H., Li, Q., Song, W., Yang, H.-M., Kim, S., Park, S.-C., Ahn, J., & Youn, H. (2018) · BMC Veterinary Research · doi:10.1186/s12917-018-1671-1 · Cited by 16
Nonalcoholic Fatty Liver Disease
Puri, P., & Sanyal, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00053-x · Cited by 17
Commentary: Mitochondrial DNA damage and loss in diabetes
Gilkerson, R. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2833 · Cited by 16
Flori, L., Piragine, E., Calderone, V., & Testai, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122491 · Cited by 16
Pelt, D. W. V., Newsom, S. A., Schenk, S., & Horowitz, J. F. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.70 · Cited by 17
4-Hydroxyisoleucine improves hepatic insulin resistance by restoring glycogen synthesis in vitro.
Lu, F., Qin, C., Zafar, M. I., Cai, L., Du, W. J., Jian, L., Li, L., & Gao, F. (2015) · Europe PMC (PubMed Central) · Cited by 18
Salmon, A. B., Flores, L. C., Li, Y., Remmen, H. V., Richardson, A. G., & Ikeno, Y. (2012) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v2i0.17101 · Cited by 15
“thought to cause insulin resistance by activating stresssignaling pathways like the JNK (c-Jun N-terminal kinases) pathway (13).”
BackgroundRole of anthraquinones in combating insulin resistance
Xia, W., Li, S., Li, L., Zhang, S., Wang, X., Ding, W., Ding, L., Zhang, X., & Wang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1275430 · Cited by 14
Kim, D., Kim, Y.-J., Chang, S., Lee, H., Kim, H., Kim, H., Chang, H., Sohn, D., & Park, Y.-B. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq103 · Cited by 13
“TNF- a has been shown to stimulate FFA synthesis and cause FFA-induced insulin resistance.(25)”
BackgroundMolecular Mechanisms of Insulin Resistance
Draznin, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_4 · Cited by 15
Regulation of Appetite and Insulin Signaling in Inflammatory States
TELI, T., XANTHAKI, D., & Karalis, K. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.022 · Cited by 13
Haupt‐Jorgensen, M., Buschard, K., Hansen, A. K., Josefsen, K. E., & Antvorskov, J. C. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2802 · Cited by 13
Li, S., Mbong, E. F., John, D. T., Terasaka, T., Li, D., & Lawson, M. A. (2018) · Endocrinology · doi:10.1210/en.2017-00638 · Cited by 13
“throughwhich FFA can influence gonadotropin synthesis or secretion (47, 48).”
BackgroundPreliminary Evidence for Adipocytokine Signals in Skeletal Muscle Glucose Uptake
Kudoh, A., Satoh, H., Hirai, H., Watanabe, T., & Shimabukuro, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00295 · Cited by 14
Self-citationUnoki‐Kubota, H., Bujo, H., Shibasaki, M., & Saitō, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.054 · Cited by 14
Importance of insulin resistance to vascular repair and regeneration
Cubbon, R. M., Mercer, B. N., Sengupta, A., & Kearney, M. T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.028 · Cited by 15
Does Childhood Obesity Trigger Neuroinflammation?
Zingale, V. D., D’Angiolini, S., Chiricosta, L., Calcaterra, V., Selvaggio, G. G. O., Zuccotti, G., Destro, F., Pelizzo, G., & Mazzon, E. (2022) · Biomedicines · doi:10.3390/biomedicines10081953 · Cited by 12
“FFA are involved in inflammatory processes through the activation of the Toll-like receptor family (TLR) [21] and by activation of IκB kinases (IKK) [41].”
BackgroundXie, W., Zhai, Z., Yang, Y., Kuang, T., & Wang, C. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0793-8 · Cited by 14
Ingianni, A., Piras, E., Laconi, S., Angius, F., Batetta, B., & Pompei, R. (2013) · PubMed · Cited by 12
Dias, J. P., Schrack, J. A., Shardell, M. D., Egan, J. M., & Studenski, S. A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.015 · Cited by 12
“Additionally, excess levels of FFA are known to impair insulin receptor activity via the accumulation of FFA derived metabolic products that promote the activation of several intracellular molecular mechanisms such as activation of serine/threonine kinases, JNK (c-jun aminoterminal kinases), IKKb (inhibitor of nuclear…”
White, K. A., Hutton, S. R., Weimer, J. M., & Sheridan, P. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.007 · Cited by 14
Kulkarni, A. V., Sharma, M., Kumar, P., Simhadri, V., Sowmya, T. R., Sasikala, M., Reddy, D. N., & Rao, P. N. (2020) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.07.010 · Cited by 12
Differential Effect of Electroacupuncture on Inflammatory Adipokines in Two Rat Models of Obesity
Liaw, J. J. T., & Peplow, P. V. (2016) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2016.02.002 · Cited by 12
Towards an Insulin Resistant Adipose Model on a Chip
Tanataweethum, N., Zhong, F., Trang, A., Lee, C., Cohen, R., & Bhushan, A. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00636-x · Cited by 13
The role of omega-3 fatty acid receptor GPR120 in insulin resistance
Oh, D., & Walenta, E. (2014) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2014.5 · Cited by 11
Abbott, M. J., Constantinescu, S., & Turcotte, L. P. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.064402 · Cited by 13
“Furthermore, insulin resistance has been shown to be associated with an inflammatory response and with increased circulating and cellular lipids and/or obesity (Boden et al. 2005; Nguyen et al. 2005).”
BackgroundPreston, K. J., Rom, I., Vrakas, C. N., Landesberg, G. P., Etwebi, Z., Muraoka, S., Autieri, M. V., Eguchi, S., & Scalia, R. G. (2019) · The FASEB Journal · doi:10.1096/fj.201802637rr · Cited by 12
Metadata
- Authors
- Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Olefsky, Jerrold M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 280
- Issue
- 42
- Pages
- 35361-35371
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2122660225
- Cited by
- 411
- References
- 47
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 10 · 2020: 16 · 2019: 21 · 2018: 12 · 2017: 20 · 2016: 17 · 2015: 23 · 2014: 32 · 2013: 26 · 2012: 15
- FWCI
- 20.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5480 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-33651)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- insulin resistance, free fatty acids, c-Jun N-terminal kinase, TNF-α, 3T3-L1 adipocytes, insulin receptor signaling, GLUT4 translocation, glucose transport, IKKβ, SOCS3, adiponectin, TNF signaling, autocrine and paracrine signaling, high-fat feeding
- MeSH terms
- Suppressor of Cytokine Signaling 3 Protein, Animals, Biological Transport, Cell Differentiation, Deoxyglucose, Enzyme Activation, Enzyme-Linked Immunosorbent Assay, Fatty Acids, Nonesterified, Genes, Dominant, Glucose, Inflammation, Insulin, Insulin Resistance, Lipids, Time Factors, Tumor Necrosis Factor-alpha, Blotting, Western, Signal Transduction, Down-Regulation, Adipocytes, Protein Transport, RNA Interference, 3T3-L1 Cells, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Suppressor of Cytokine Signaling Proteins, Glucose Transporter Type 4, Mice, I-kappa B Kinase, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.